Face it fellow investors. A marketing distribution agreement with a single foreign sovereign rep. is not going to move stock price, Investor confidence has been eroded too much for too long. There are only three things that will move Generex: Lsiting of NGIO and Uplist of GNBT, IND approval, or a big pharma or financial partner buy-in. No more talk of future expectations, intentions, initiatives or completion of interim procedural hurdles are going to matter. Probably treading more water in offing but things could deteriorate further.